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Abstract
The ancestral equine herpesvirus 1 (EHV1), closely related to human herpes viruses, exploits leukocytes to reach its target 
organs, accordingly evading the immune surveillance system. Circulating EHV1 strains can be divided into abortigenic/neuro-
virulent, causing reproductive/neurological disorders. Neurovirulent EHV1 more efficiently recruits monocytic CD172a+ cells 
to the upper respiratory tract (URT), while abortigenic EHV1 tempers monocyte migration. Whether similar results could be 
expected for T lymphocytes is not known. Therefore, we questioned whether differences in T cell recruitment could be associ-
ated with variations in cell tropism between both EHV1 phenotypes, and which viral proteins might be involved. The expression 
of CXCL9 and CXCL10 was evaluated in abortigenic/neurovirulent EHV1-inoculated primary respiratory epithelial cells (ERECs). 
The bioactivity of chemokines was tested with a functional migration assay. Replication of neurovirulent EHV1 in the URT 
resulted in an enhanced expression/bioactivity of CXCL9 and CXCL10, compared to abortigenic EHV1. Interestingly, deletion of 
glycoprotein 2 resulted in an increased recruitment of both monocytic CD172a+ cells and T lymphocytes to the corresponding 
EREC supernatants. Our data reveal a novel function of EHV1-gp2, tempering leukocyte migration to the URT, further indicating 
a sophisticated virus-mediated orchestration of leukocyte recruitment to the URT.
InTRoduCTIon
Chemokines are a large family of low-molecular-weight 
proteins that belong to the cytokine superfamily. They act 
through binding to their corresponding G protein-coupled 
receptors. It has become clear that specific chemokines and 
their receptors provide the molecular code responsible for 
the coordination of leukocyte trafficking [1, 2]. Together 
with their highly recognized roles in cell migration, these 
small proteins have multiple other functional properties, 
including cell survival and proliferation [3]. Their regulatory 
role in pathological and physiological perspectives result from 
hypersensitivity reactions, infections, angiogenesis, inflam-
mation, tumour growth and haematopoietic development 
[2, 4–6]. Numerous studies have indicated that viruses that 
infect the respiratory tract, such as influenza virus, rhinovirus 
and herpes simplex virus 1 (HSV1), drive chemokine expres-
sion in the respiratory epithelium, resulting in the attraction 
of immune cells to the site of infection [7]. The upregulation 
of chemokine expression is mediated by two distinct mecha-
nisms. First, pathogen-associated molecular pattern (PAMP) 
receptors at the mucosal surfaces recognize viral products 
such as HSV1 gH/gL and gB glycoproteins, viral RNA and 
CpG motifs, resulting in signal transduction through the 
ancestral PAMP recognition pathways [8, 9]. These signaling 
cascades induce the production of inflammatory chemokines 
either directly through nuclear factor kappa b (NF-κB) and 
mitogen-activated protein kinase (MAPK) activation and 
translocation to the nucleus, resulting in the transcription 
and translation of pro-inflammatory cytokines. Alternatively, 
inflammatory chemokines can become expressed indirectly 
through the expression of pro-inflammatory cytokines, such 
as type I IFN, TNFα, IL-1 and IL-6, which initiate the inflam-
matory response through the upregulation of NF-κB [10–13]. 
Secondly, antigen recognition by specific lymphocytes also 
drives chemokine expression, either directly or indirectly 
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through the production of IFN and TNFα [14, 15]. Control-
ling herpes virus infections at the primary site of infection 
requires recruitment of immune cells, such as natural killer 
(NK) cells, T lymphocytes and monocytic cells [16, 17]. Those 
immune cells control viral replication through direct lysis of 
infected cells and cytokine production [18]. Type I IFN and 
CCL3 enhance NK cell recruitment to the site of infection 
[19, 20]. Monocytic cells are mainly recruited by monocyte 
chemoattractant protein-1 (MCP1 or CCL2) and, to a lesser 
extent, CCL5 (or RANTES) expressed by infected epithelial 
cells [18]. Multiple chemokines are described to attract T 
lymphocytes, including CXCL9 and CXCL10 [21].
Despite the protective antiviral effects of leukocytes, many 
viruses including several alphaherpes viruses are known to 
infect the cellular arm of the immune response as an immune 
evasive strategy to persist in their host. Equine herpes virus 
type 1 (EHV1), a virus closely related to the ubiquitous 
human HSV1 and varicella zoster virus (VZV), causes upper 
respiratory tract (URT) infections, abortion and neurological 
disease in horses worldwide [22, 23]. Respiratory problems 
occur upon primary viral replication in the epithelium of the 
URT. Although respiratory replication may have a subclinical 
outcome, clinical symptoms can include nasal discharge, fever 
and cough. EHV1 infects monocytic CD172a+ cells and T 
lymphocytes and misuses these cells to cross the basement 
membrane and enter the blood circulation [24, 25]. During 
this cell-associated viraemia, EHV1 disseminates through the 
body and migrates to the secondary site of replication, the 
endothelium of the pregnant uterus or the central nervous 
system [22]. Abortions tend to occur after the seventh 
month of gestation [26]. Neurological disorders frequently 
present with hindlimb ataxia, atonia of the urine bladder and 
decreased tail tonus [27, 28]. Interestingly, EHV1 isolates 
circulating in the field can be differentiated as abortigenic, 
causing reproductive disorders, or neurovirulent variants, 
causing neurological disorders, based on a single nucleotide 
polymorphism in the gene that codes for DNA polymerase 
[29]. In the last 10 years, numerous researchers have reported 
unambiguous differences between both EHV1 phenotypes, 
essentially in the pathogen–host interactions [25, 30–35]. 
Vandekerckhove and colleagues [25] showed that neuroviru-
lent variants infect three times more monocytic CD172a+ cells 
earlier [24 h post-infection (p.i.)] in infection, compared to 
the abortigenic variants (36 h p.i.). At 24 h p.i., only neuro-
virulent strains were able to infect T lymphocytes. Later in 
infection (48-72 h p.i.), abortigenic variants infect four times 
more T lymphocytes compared to the neurovirulent variants. 
These findings were supported by the ex vivo study of Zhao et 
al. [33]. They showed that migration of monocytic CD172a+ 
cells is controlled by upregulation of the expression of mainly 
chemo-attractant CCL2 at the primary site of infection. In 
addition, they demonstrated that primary replication of 
neurovirulent EHV1 variants attracted monocytic CD172a+ 
cells more efficiently to the site of infection, resulting in a 
faster and more efficient infection of monocytic cells. There-
fore, we hypothesized that neurovirulent variants might 
attract at an early stage also more T lymphocytes to the URT 
compared to abortigenic EHV1 strains, possibly by upregu-
lating T lymphocyte-specific chemokines such as CXCL9 and 
CXCL10. Moreover, we questioned which viral proteins might 
influence the recruitment of mononuclear cells to the site of 
infection. Indeed, previous studies have demonstrated that the 
early glycoprotein G (gG) has chemokine binding activities. 
Interestingly, gG is conserved among different herpes viruses, 
including EHV1 [36]. von Einem et al. [37] showed that gG 
of EHV1 binds cellular chemokines and subsequently blocks 
their chemokine activity by preventing interaction with their 
corresponding receptors. Alongside gG, we hypothesized 
that other viral proteins might interact with the chemokine 
network in the URT. One putative candidate is the late viral 
glycoprotein 2 (gp2). This heavily O-glycosylated glycopro-
tein shows structural similarities with mucins, suggesting 
a similar mechanism of action. Interestingly, chemokine 
receptor (CCR) 5 in humans is heavily O-glycosylated in 
the chemokine-binding site at the N terminus, suggesting a 
putative role of the O-sulfated sugar moieties in the interac-
tion with chemokines [38]. Additionally, deletion mutants of 
mucin-like glycoproteins of other viruses, such as paramyxo-
viruses, have been associated with elevated levels of cytokines, 
chemokines and type I IFN effects, resulting in a reduced viral 
replication in the URT [39–41]. In herpes viruses, alongside 
gp2 of EHV1, only HSV2 gG has been described to be heavily 
O-glycosylated [42].
In the present study, we used primary respiratory epithelial 
cells (ERECs) to visualize the expression of CXCL9 and 
CXCL10 upon infection with abortigenic and neuroviru-
lent EHV1 variants. In addition, we analysed whether the 
produced chemokines are bioactive, and efficiently recruit 
mononuclear cells to the primary site of infection. Finally, 
we questioned which viral proteins might be involved in 
the viral interplay with immune modulatory chemokines. 
Understanding how EHV1 exploits chemokines to orches-
trate its dissemination in the host is of key importance 




Different Belgian EHV1 isolates were included in this study 
and were genotyped in the ORF30 region by the Animal 
Health Trust in the UK. The EHV1 abortigenic strains 97P70, 
438/77 and RacL11 were originally isolated from an aborted 
fetus, and encode an asparagine at amino acid position 752 
(N752) [43–45]. Strains 438/77 and the RacL11 lacking gG 
(438/77∆gG) or gp2 (RacL11∆gp2) were constructed by 
Huang et al [46]. and Rudolph et al. [47], respectively. The 
neurovirulent 03P37 and 95P105 EHV1 strains were isolated 
in 2003 and 1995, respectively, from the blood of a paralytic 
horse [48], and encode aspartic acid at amino acid position 
752 (D752). The last passage of each strain was performed in 
RK-13 cells.
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donor horses
Respiratory tissues from horses were collected post mortem 
at the moment of slaughter, in the slaughterhouse. Horses 
negative for ocular/nasal discharge and lung pathologies were 
selected. The horses were aged between 5 and 15 years old, as 
determined by inspection of dental incisive architecture [49]. 
Each experiment was conducted with primary cells isolated 
from three different horses. The proximal part of the trachea 
was collected from each horse. Tissues were transported to the 
laboratory on ice, in PBS, supplemented with 1 % gentamycin, 
1 % penicillin-streptomycin (Gibco), 1 % kanamycin (Sigma-
Aldrich) and 0.5 % amphotericin B (Bristol-Myers Squibb).
Cells
Isolation and cultivation of primary respiratory epithelial 
cells
The isolation and cultivation of ERECs was conducted as 
previously described [32, 50]. Briefly, equine tracheal tissues 
were washed twice with cold Dulbecco’s PBS (DPBS; Gibco) 
to remove red blood cells. Epithelial cells were isolated by an 
enzymatic digestion using gentle agitation in calcium- and 
magnesium-free minimal essential medium (MEM; Gibco) 
containing 1.4 % pronase (Roche Applied Science) and 0.1 % 
deoxyribonuclease I (Sigma-Aldrich). Tissues were incubated 
at 4 °C for 48 h with the enzyme mix. Cells were cultured in 
a plastic uncoated Petri dish for 6 h in DMEM/F12 (Gibco) 
containing calcium- and magnesium-free MEM, 1 % peni-
cillin-streptomycin and 2.4 μg insulin ml−1 (Sigma-Aldrich) 
to reduce fibroblast contamination. ERECs were seeded at a 
concentration of 1.8×106 cells per well into type IV collagen- 
(Sigma-Aldrich) coated transwell cell culture wells of 0.4 
μm pore size (Costar, Corning, Fisher Scientific) in DMEM/
F12, containing 5 % non-heat-inactivated FBS (Gibco), 1 % 
calcium- and magnesium-free MEM, 1% penicillin-strep-
tomycin and 0.5 % amphotericin B. After 24 h of culture, 
ERECs were cultivated at the air–liquid interface in epithelial 
cell medium containing DMEM/F12 supplemented with 2 % 
Ultroser G (Pall Life Sciences), 1 % penicillin-streptomycin 
and 0.5 % amphotericin B. ERECs were incubated in a 37 °C, 
5 % CO2, humidified incubator to confluency.
Isolation of monocytic Cd172a+ cells and T lymphocytes
Peripheral blood was sampled from the external vena 
jugularis into heparin (Leo) at a final concentration of 15 
U ml−1. The Ethical Committee of the Faculty of Veterinary 
Medicine, Ghent University (EC2017/118), approved the 
collection of blood. Fresh blood was diluted in an equal 
volume of DPBS without calcium and magnesium (Gibco). 
Peripheral blood mononuclear cells (PBMCs) were isolated 
as described by Poelaert et al. [35], by density centrifuga-
tion on Ficoll-Paque (d=1.077 g ml−1) (GE Healthcare, Life 
Sciences) at 800 g for 30 min at 18 °C. The interphase band, 
containing the PBMCs, was collected and washed three times 
with DPBS. Cells were resuspended in complete medium 
based on Roswell Park Memorial Institute (RPMI) medium 
(Gibco), supplemented with 5 % newborn FCS (Gibco), 1 
% MEM non-essential amino acids, 1 % sodium pyruvate, 
1 % penicillin-streptomycin and 0.5% gentamycin (Gibco). 
PBMCs were then seeded at a concentration of 5×106 cells ml–1 
in a plastic Petri dish and cultivated at 37 °C with 5 % CO2. 
After 2 h, non-adhering leukocytes were removed by washing 
cells three times with RPMI medium and the adherent cells 
were cultured in complete medium. Non-adherent cells were 
washed three times with ice-cold RPMI. The cell pellet was 
incubated with 400 μl of mouse monoclonal (mAb) anti-horse 
pan B-cell, clone CVS36 (IgG1; 1:50) (Bio-Rad), diluted in 
ice-cold DPBS, for 1 h at 4 °C with gentle agitation. Cells were 
then washed once in magnetic-activated cell sorting (MACS) 
buffer containing DPBS supplemented with 1 mM EDTA and 5 
% newborn FCS and incubated with 400 μl rat anti-mouse IgG 
microbeads (MACS Miltenyi Biotec) diluted in MACS buffer 
(1:5), for 1 h at 4 °C with gentle agitation. Next, the cells were 
washed once in MACS buffer and resuspended in 3 ml MACS 
buffer for application to the MACS column. The unbound 
cells of the pan-B-cell antibody-incubated T lymphocytes 
were collected from the column and consisted of >90 % of 
CD3+ cells, assessed by flow cytometry after incubation with 
an mAb anti-CD3, clone UC-F6G (IgG1; 1:50) (UCDavis), 
directed against cells from the T cell lineage, followed by 
goat anti-mouse IgG FITC (1:200) (Molecular Probes). All 
T lymphocytes were cultured in basal medium [RPMI, 1 % 
MEM non-essential amino-acids, 1 % sodium pyruvate, 1 % 
BSA (Sigma-Aldrich) and antibiotics] supplemented with 4 
U ml−1 recombinant interleukin-2 (hIL-2) (R&D systems) 
and 50 mM β-mercaptoethanol (β-ME) (Gibco). IL-2 is a 
prototypical T lymphocyte growth factor, which stimulates 
T cell survival and proliferation in vitro [51, 52]. After 6 h 
of cultivation, medium of the adherent monocytic cells was 
substituted by basal medium. The next day, CD172a+ mono-
cytic cells were detached from the plastic by incubation with 
Accumax solution (Sigma-Aldrich) for 30 min at 37 °C, 5 
% CO2. Monocytic cells and T lymphocytes were washed in 
ice-cold RPMI, centrifuged at 300 g and resuspended in basal 
medium.
EHV1 inoculation of primary respiratory epithelial 
cells (ERECs)
The basolateral inoculation of ERECs was executed as 
described by Van Cleemput et al. [53]. ERECs were (mock-) 
inoculated with 100 μl inoculum containing strains 97P70, 
438/77, 438/77∆gG, RacL11, RacL11∆gp2, 03P37 or 95P105 
EHV1 at an m.o.i. of 0.1. After 45 min of incubation, non-
absorbed virus particles were removed by washing the 
ERECs three times with DMEM/F12. Fresh EREC medium 
was added to the bottom plate wells and cells were further 
incubated at the air–liquid interface. At 24 h p.i., ERECs were 
fixed in methanol for 20 min at –20 °C, and stored at –20 °C 
until further processing.
Chemotaxis assay
Supernatants of mock- or EHV1-inoculated ERECs were 
collected at 24 h p.i. Chemotactic activity of the superna-
tants was determined using a 96-well Boyden chamber 
containing 5-μm pore size membranes (CytoSelect, Cell 
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Biolabs), following the manufacturer’s guidelines. Briefly, 
supernatants of the mock- or EHV1-inoculated ERECs 
(150 μl) were applied to the wells of the feeder tray, before 
inserting the membrane tray. Medium containing 10 % FCS 
(Gibco) was included as a positive control. Equine CD172a+ 
monocytic cells or T lymphocytes were resuspended in basal 
medium containing RPMI supplemented with antibiotics, at a 
concentration of 5×106 cells ml−1, and 100 μl of each cell-type 
solution was added to the membrane tray. The chemotaxis 
chamber was transferred to 37 °C, 5 % CO2 for 24 h, followed 
by dislodging the cells from the underside of the membrane 
in the harvesting tray. In a clean 96-well plate, 75 μl from the 
feeder tray and 75 μl from the harvesting tray were mixed 
with 50 μl of lysis buffer, containing CyQuant GR dye. Finally, 
150 μl of the mixture, containing lysis buffer and dye, was 
transferred to a new 96-well plate, suitable for fluorescence 
measurement (Greiner). Cell migration was analysed by a 
Fluoroskan Ascent FL (ThermoFisher Scientific) plate reader. 
Cell migration values were measured at 480/520 nm, and 
were reported as fluorescence units (FU). The background 
FU-value was subtracted from the values of the supernatants 
of the mock-inoculated ERECs. FU-values of mock-inocu-
lated ERECs were equalized as 1. Next, relative FU values were 
calculated as the percentage of the corresponding virus titre 
of the ERECs (FU-value/virus titre).
Indirect immunofluorescence staining
Protocol
At 24 h p.i., ERECs were pre-treated with brefeldin A (BFA; 
Sigma-Aldrich) at 10 μg ml−1 for 45 min prior to fixation. 
EHV1 proteins were stained with biotinylated equine poly-
clonal anti-EHV1 IgG antibody (1:20 in DPBS) [48], followed 
by streptavidin TR (1:200 in DPBS) (Molecular Probes). 
CXCL9 and CXCL10 were visualized by incubating with a 
rabbit polyclonal anti-CXCL9 antibody (IgG; GeneTex) (1:50 
in DPBS) or a rabbit polyclonal anti-CXCL10 antibody (IgG; 
Kingfisher Biotech) (1:50 in DPBS) followed by an FITC-
conjugated goat anti-rabbit IgG antibody (1:100 in DPBS) 
(Molecular Probes). In parallel, ERECs were incubated with 
irrelevant isotype controls (1:50 in DPBS). All antibodies 
were incubated for 1 h at 37 °C. All antibodies were diluted 
in DPBS. Cell nuclei were counterstained with Hoechst 33342 
(10 μg ml−1) (Molecular Probes).
Analysis of expression of CXCL9 and CXCL10
Five viral plaques per condition per horse were analysed. The 
intensity of chemokine expression in the respiratory epithe-
lium was measured using ImageJ software (US National Insti-
tutes of Health). The region of interest (ROI, i.e. viral plaques) 
was drawn manually for each picture in the ‘ROI manager 
tool’. Next, the threshold value to distinguish between regions 
with or without chemokine expression was determined, and 
the percentage of chemokine-positive area was calculated.
Confocal microscopy
Immunofluorescence of cryosections and ERECs was analysed 
by confocal microscopy (Leica TCS SP2 Laser Scanning 
Spectral Confocal System; Leica Microsystems). A Gre-Ne 
543 nm laser was used to excite Texas Red fluorochromes. An 
Ar 488 nm laser excited FITC fluorochromes.
Prediction of O-glycosylation sites
The predicted O-glycosylation sites of the amino acid 
sequence of gene 70 (encoding gG) and gene 71 (encoding 
gp 2) of abortigenic and neurovirulent EHV1 strains were 
obtained through  NetOglyc@ cbs. dtu. dk, using the algorithm 
of Hansen et al. [54], as previously described by Wellington 
et al. [55].
Three-dimensional model viral glycoproteins
The predictive three-dimensional model of gG and gp2 were 
obtained through I-Tasser (http:// zhanglab. ccmb. med. umich. 
edu), and was analysed with the Pymol Protein Viewer.
Statistical analyses
We analysed the data for statistical significance via a multiple-
way ANOVA. If the assumption of equal variables was not 
fulfilled with Levene’s test, the data were log-transformed prior 
to ANOVA. If the normality of the residuals was not achieved 
after log-transformation, a Kruskal–Wallis test followed by 
a Mann–Whitney post-hoc test was performed. Differences 
in results with P-values <0.05 were considered statistically 
significant. The data shown represent the means+sd of inde-
pendent experiments. Data were statistically evaluated with 
IBM SPSS Statistics for Windows, version 24.0 (IBM).
RESuLTS
CXCL9 and CXCL10 are upregulated during EHV1 
replication in ERECs
At 12 or 24 h p.i., ERECs were treated with 10 μg BFA ml−1 to 
prevent chemokine secretion from the cell and to optimize 
CXCL9 and CXCL10 visualization by immunofluorescence 
staining. The expression of CXCL9 could be observed at 12 
h p.i. (data not shown) and visibly co-localized with viral 
plaques of both EHV1 variants at 24 h p.i. for all EHV1 
strains (Fig. 1a). EHV1-inoculated ERECs detached at 36 
h p.i., which prevented staining of chemokines at later time 
points. Therefore, all subsequent experiments were conducted 
at 24 h p.i. At 24 h p.i., the intensity of CXCL9 expression was 
slightly higher in epithelial cells inoculated with the neuro-
virulent 03P37 and 95P105 strains compared to that of cells 
inoculated with the abortigenic 438/77 strain (P=0.055 and 
P=0.141, respectively). No significant difference was observed 
between both neurovirulent strains and the abortigenic 
97P70 (P>0.05). The expression pattern of CXCL10 clearly 
differed from that of CXCL9. In the area of a viral plaque, only 
single cells were CXCL10-positive, and no differences were 
observed between EHV1 variants (P>0.05). Positive cells were 
not observed in the non-inoculated areas of the epithelium 
(Fig. 1b). Together, we demonstrated that the replication of 
both EHV1 variants activates the chemokine response to a 
greater (CXCL9) or lesser (CXCL10) extent in the respira-
tory epithelium. The expression of CXCL9 was more apparent 
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Fig. 1. Expression patterns of CXCL9 and CXCL10 in mock-, abortigenic (N752) EHV1, or neurovirulent (D752) EHV1-inoculated ERECs. 
The left panel shows representative confocal images of the immunofluorescence staining, with (a) CXCL9 or (b) CXCL10 stained in green 
(FITC), viral proteins stained in red (TR), and nuclei counterstained in blue (Hoechst) in mock- or EHV1-inoculated ERECs, at 24 h p.i. Bars, 
75 µm. The right panel shows the intensity of CXCL9 or CXCL10 signal in the ERECs at the level randomly chosen for viral plaques. Data 
are represented as means+sd, and ns indicates no statistically significant differences. *Statistically significant differences at P<0.05. 
Experiments were performed with ERECs isolated from three individual horses.
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upon infection with the neurovirulent variant, compared to 
the abortigenic variant. In contrast, CXCL10 was expressed 
only by single cells in viral plaques of both viral strains.
Replication of EHV1 in ERECs induces the 
recruitment of mononuclear cells to the site of 
infection
Zhao et al. [33] indicated the upregulation of CCL2 in the 
respiratory mucosa upon infection with the neurovirulent 
EHV1 variant. This was less efficient upon inoculation with 
EHV1 strains of the abortigenic phenotype. These results 
were confirmed in the current EREC model, as shown in Fig. 
S1 (available with the online version of this article). Thus, 
replication of neurovirulent and, to a lesser extent, abortigenic 
EHV1 in respiratory epithelial cells induces chemokine secre-
tion. To determine whether these chemokines are biologically 
active and recruit monocytic CD172a+ cells and T lympho-
cytes to the site of infection, a functional migration assay was 
performed. First, we analysed the replication of both variants 
in ERECs. No significant differences in extracellular virus titre 
were observed between the included EHV1 strains (P=0.111) 
(Fig. 2a). Next, we measured the chemotactic activity of the 
supernatants of mock- or EHV1-inoculated ERECs in a cell 
migration assay. As viral replication induces the produc-
tion of chemokines, data are shown as a relative FU-value 
normalized to the corresponding virus titre. Supernatants 
of both abortigenic and neurovirulent EHV1-inoculated 
ERECs attracted monocytic CD172a+ cells and T lympho-
cytes (Fig. 2b). However, supernatants derived from ERECs 
inoculated with the neurovirulent 03P37 or 95P105 EHV1 
strains attracted more monocytic CD172a+ cells (13.8±10.9 
or 12.7±1, respectively), compared to that of the abortigenic 
97P70 (0.5±0.6) (P<0.05) or 438/77 EHV1 strains (4.1±0.3) 
(P<0.05). In addition, the neurovirulent 03P37 and 95P105 
strains recruited significantly more T lymphocytes (22.3±17.8 
and 13.0±1.0), compared to the supernatant derived from 
97P70 (0.9±1.3) (P<0.05) and 438/77 (4.1±0.3) (P<0.05) 
EHV1-inoculated ERECs. Together, we observed differences 
in the chemotactic capacities of the supernatants of ERECs 
inoculated with EHV1 strains belonging to the different 
phenotypes. We found that the replication of neuroviru-
lent 03P37 and 95P105 strains in the in vitro EREC-model 
attracted more monocytic CD172a+ and T cells compared to 
the included abortigenic 97P70 and 438/77 EHV1 strain.
Early gG and late gp2 temper the recruitment of 
mononuclear cells to the uRT
gG of several alphaherpes viruses, including EHV1, is known 
as a chemokine-binding protein [36, 56–58]. It binds to 
chemokines with high affinity and inhibits their biological 
activity by preventing their interaction with specific cell 
receptors [56]. First, we evaluated the replication kinetics 
of EHV1-∆gG in ERECs. The number of plaques induced 
by EHV1-∆gG was not significantly different compared to 
the parental EHV1 strain (P>0.05) (Fig. 3a, left panel). The 
latitude of the 438/77∆gG-induced viral plaques was slightly 
larger compared to the parental strain (P=0.109) (Fig. 3a, 
middle panel). The extracellular virus titre measured in the 
supernatant of 438/77∆gG inoculated ERECs (1±1 log10 
TCID50 ml−1) was slightly but not significantly lower than 
the virus titre of the parental 438/77 (4.0±4.0 log10 TCID50 
ml−1) (P=0.272) (Fig. 3a, right panel). Because the replica-
tion kinetics of parental and mutant EHV1 strains differ, 
we standardized the FU-values based on the corresponding 
virus titres. Deletion of gG resulted in a 91±51-fold increase 
in the migration of monocytic CD172a+ cells (P<0.05), and a 
86±61-fold increased migration of T lymphocytes (P<0.05), 
compared to the parental strain (Fig. 3B).
Fig. 2. Abortigenic (N752) and neurovirulent (D752) EHV1 replication in ERECs induce the production of bioactive chemokines. (a) Virus 
titre of the abortigenic (97P70 and 438/77) and neurovirulent (03P37 and 95P105) EHV1-inoculated ERECs. (b) Chemotactic activities 
of the supernatants of the abortigenic (97P70 and 438/77) or neurovirulent (03P37 and 95P105) EHV1-inoculated ERECs were tested 
in a cell recruitment assay. Results are shown as a percentage of the corresponding virus titre. Data are shown as means+sd, different 
letters indicate statistically significant differences, and ns indicates not statistically significant differences. Experiments were performed 
with supernatants of ERECs derived from three individual horses.
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In order to determine whether variations in EHV1-gG might 
be associated with the different chemokine activity of both 
EHV1 phenotypes, the amino acid sequence of the abortigenic 
and neurovirulent EHV1 strains were compared. No apparent 
variations at the level of amino acid sequence or in glycosyla-
tion were observed, suggesting no alteration between abor-
tigenic and neurovirulent EHV1 variants (Fig. 3c). Lacking 
the availability of a full sequence of 438/77, we were not able 
to include the amino acid sequence of gG of the abortigenic 
438/77 strain.
In parallel, we analysed the role of the mucin-like late gp2 in 
the orchestration of leukocyte migration to the URT. First, we 
evaluated the replication kinetics of the EHV1 gp2-deletion 
mutant in ERECs by analysing the number and latitude of viral 
plaques, and virus titration. The number of RacL11∆gp2 viral 
plaques was significantly lower compared with the parental 
strain (P<0.05) (Fig. 4a, left panel). No differences in plaque 
latitudes (Fig. 4a, middle panel) or virus titre (Fig. 4a, right 
panel) of EHV1-∆gp2 and the parental strain were observed 
in ERECs (P>0.05). Deletion of gp2 led to an 8±6-fold 
(P<0.05) and 24±9-fold (P<0.05) increase in the recruitment 
of monocytic CD172a+ cells and T lymphocytes, respectively, 
compared to the parental virus (Fig. 4a). Remarkably, indi-
rect immunofluorescence staining of ERECs inoculated with 
RacL11∆gp2 did not show any alterations in the CXCL9 
chemokine expression compared to their corresponding 
parental strain (Fig. 4c and d). A careful analysis of the amino 
acid sequence of the 03P37 neurovirulent EHV1 strain, and 
different abortigenic EHV1 strains, indicated alterations in 
the amino acid sequence of gp2 (Fig. 5a). We included 97P70, 
RacL11 (GenBank accession number MF975656.1) and 438/77 
(GenBank accession number AY034645.1) abortigenic EHV1 
strains and 03P37 neurovirulent EHV1 strain. Because the 
full genome sequence of 95P105 is not available, we were not 
able to include this strain in the sequence analysis. Multiple 
variations were observed at amino acid position 196 until 
Fig. 3. gG impedes the recruitment of mononuclear cells to the EHV1-infected respiratory epithelium. (a) Replication kinetics of the gG-
deletion mutant, and their corresponding parental strain in ERECs. (b) Recruitment of monocytic CD172a+ cells and T lymphocytes to 
the supernatants of the ERECs, inoculated with the gG-deletion mutant and their parental strain, shown as the relative FU-value as a 
percentage of the corresponding virus titre. (c) Alignment of gG (pORF70) amino acid sequences of neurovirulent 03P37 and abortigenic 
97P70 and RacL11 EHV1 strains. Dots represent residues that are identical, and hyphens indicate gaps. Blank dotted boxes indicate 
regions with variations between the indicated EHV1 strains. Blue boxes indicate predicted N-glycosylation sites. Red or blue labelled 
letters indicate predicted O-glycosylated serine or threonine, respectively, residues with a prediction strength of more than 0.5. The 
yellow box indicates the transmembrane region.
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position 253. We mainly observed substitutions between the 
polar, hydrophilic amino acids serine (S) or threonine (T), and 
the aliphatic, hydrophobic alanine (A). The latter amino acid 
alterations resulted in an extra β-sheet in the gp2 structure of 
the abortigenic variant (Fig. 5b). In addition, variations at the 
protein level resulted in variations in glycosylation. Indeed, at 
amino acid positions 601, 629 and 630 we observed variations 
in O-glycosylation between the included EHV1 strains. The 
neurovirulent 03P37 EHV1 strain and abortigenic RacL11 
strain were both O-glycosylated at all three positions, while 
the 97P70 abortigenic EHV1 strain was not. The abortigenic 
438/77 EHV1 strain was only O-glycosylated at positions 601 
and 629. This sequence analysis of different EHV1 strains 
might explain the alterations in recruitment of immune cells 
to the site of infection.
Taken together, we confirmed that EHV1-gG impedes the 
recruitment of monocytic CD172a+ cells and T lymphocytes 
to the epithelium of the URT. Alongside the early protein 
gG, we demonstrated that the late viral protein gp2 and 
possibly other late viral protein(s) interfere with chemokine 
activity, which may hinder the recruitment of both mono-
cytic CD172a+ cells and T lymphocytes to the EHV1-infected 
respiratory epithelium.
dISCuSSIon
Chemokines are essential at the mucosal barriers to guide 
(innate) immune effector cells to the site of tissue damage 
and pathogen replication [18]. Numerous reports have indi-
cated the importance of leukocytes in clearing herpes virus 
Fig. 4. gp2 impedes the recruitment of mononuclear cells to the EHV1-infected respiratory epithelium. (a) Replication kinetics of the 
gp2-deletion mutant, and their corresponding parental strain in ERECs. (b) Recruitment of monocytic CD172a+ cells and T lymphocytes 
to the supernatants of the ERECs, inoculated with the gp2-deletion mutant and their parental strain, shown as the relative FU-value as a 
percentage of the correspondent virus titre. (c) Representative confocal images of CXCL9 (FITC) expression in RacL11- or RacL11∆gp2-
infected ERECs viral proteins were stained with (TR). Nuclei were counterstained in blue (Hoechst). Bars, 75 µm. (d) The intensity of 
CXCL9 signal in the ERECs at the level randomly chosen for viral plaques. Data are represented as means+sd and ns indicates no 
statistical difference. *Statistically significant differences at P<0.05. Experiments were performed with supernatants of ERECs derived 
from three individual horses.
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Fig. 5. Comparison of gp2 of abortigenic and neurovirulent EHV1 strains. (a) Alignment of gp2 (pORF71) amino acid sequences of 
neurovirulent 03P37 and abortigenic 97P70, RacL11 and 438/77 EHV1 strains. Dots represent residues that are identical, and hyphens 
indicate gaps. Blank dotted boxes indicate regions with variations between the indicated EHV1 strains. Blue boxes indicate predicted 
N-glycosylation sites. Red or blue labelled letters indicate predicted O-glycosylated serine or threonine, respectively, residues with a 
prediction strength of more than 0.5. (b) Comparison of predicted three-dimensional model of the abortigenic gp2 (red) and neurovirulent 
gp2 (blue). Yellow and green lines show the region of alterations between the neurovirulent and the abortigenic gp2, respectively. 
Yellow and green sugar structures indicate N-glycosylation sites of gp2 of the neurovirulent and abortigenic EHV1 strain, respectively. 
Arrowheads indicate variation in sugar positions.
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infections. Indeed, CD8+ T lymphocytes are essential in the 
elimination of viruses at mucosal barriers. Infection of cells 
involved in the immune response may represent one of the 
strategies to overcome viral elimination. Similar to HSV1 and 
VZV, EHV1 has developed a tropism for monocytic CD172a+ 
cells and lymphocytes, as one of its multiple immune evasion 
strategies [59, 60]. Previous studies have indicated that 
neurovirulent EHV1 variants are more efficient in attracting 
and infecting monocytic CD172a+ cells and T lymphocytes 
early in infection, compared to abortigenic variants. Aborti-
genic variants are more effective in infecting T lymphocytes 
later in infection, compared to the neurovirulent variants 
[24, 25, 33–35].
Numerous chemokines are associated with the attraction of 
T cells. CXCL9 and CXCL10 are inflammatory chemokines 
that specifically target T lymphocytes through the CXCR3 
receptor. They are best known for their effects on activated 
CD4+ Th1 cells, CD8+ T cells and NK cells [61]. First, we 
questioned whether abortigenic and neurovirulent EHV1 
replication activates the production of CXCL9 and CXCL10 
in the URT. Using immunofluorescence staining, we observed 
that both EHV1 variants induce CXCL9 and CXCL10 expres-
sion in ERECs. The expression of CXCL9 clearly co-localized 
with EHV1-induced plaques, whereas CXCL10 was only 
expressed by single cells within a viral plaque. These results 
are in line with other herpes viruses, such as HSV1 and HSV2, 
indicating virus-induced expression of CXCL9 in (primary) 
human epithelial cells [62, 63]. We observed a propensity of 
enhanced CXCL9 production upon infection of ERECs with 
neurovirulent EHV1 strains, compared to the abortigenic 
strains. To examine whether the produced chemokines are 
biologically active, we included a functional cell migration 
assay. Replication of both EHV1 variants in ERECs led to 
the production of bioactive chemokines, which efficiently 
attracted mononuclear cells to the site of infection. In the 
EREC model we observed a trend of differences in the recruit-
ment of mononuclear cells to the site of infection between 
the two EHV1 phenotypes. These results are in line with 
the ex vivo study by Zhao et al. [33]. They demonstrated an 
enhanced expression of monocytic chemoattractant CCL2 
upon infection of the nasal mucosa with the neurovirulent 
variant by immunofluorescence staining. Here, we confirm 
that the produced chemokines are biologically active. Lacking 
specific equine neutralizing antibodies against chemokines 
limited the full characterization of the functional chemokines. 
Therefore, more research is needed to link the immunofluo-
rescence staining with the functional cell migration assay. Our 
results confirm the previous results of the ex vivo study of 
Vandekerckhove et al. [25]. They reported that a neuroviru-
lent EHV1 variant infects more monocytic CD172a+ cells and 
T lymphocytes earlier (24 h p.i.) in infection, compared to an 
abortigenic EHV1 variant (36 h p.i.).
Combining the results of the CXCL9/10 immunofluorescence 
staining with the functional cell migration assay, we propose 
that neurovirulent EHV1 strains stimulate the release of 
chemokines, resulting in massive recruitment and subse-
quently direct infection of monocytic CD172a+ cells and T 
cells in the URT. In contrast, the abortigenic EHV1 strains 
appear to temper and regulate the recruitment of immune 
cells to the primary site of replication during the first 36 h p.i., 
to avoid viral elimination. Next, the abortigenic EHV1 strains 
mainly target monocytic CD172a+ cells early in infection. 
Once T cells are recruited to the URT, we suggest that infected 
monocytic CD172a+ cells transfer infection to CD4+ T cells. 
Indeed, we previously demonstrated that infected monocytic 
cells efficiently transfer infection to T lymphocytes [35]. More 
research is needed to further verify this hypothesis.
One of the best-studied viral chemokine scavengers is the 
early gG [36, 56–58]. Homologues of gG are conserved 
among alphaherpes viruses, including EHV1 and EHV4 
[36]. gG of EHV1 binds to chemokines with high affinity 
and blocks chemokine activity by preventing interaction 
with their specific receptors [36, 58]. Here, we confirm the 
interaction of EHV1-gG with the chemokine network of the 
EHV1-infected ERECs. Deletion of gG resulted in increased 
chemotaxis of the main target cells of EHV1, monocytic 
CD172a+ cells and T lymphocytes. This is in line with the in 
vitro study of Viejo-Borbolla et al. [64], demonstrating that 
PrV-gG and EHV1-gG bind to specific chemokines, including 
CCL2, CCL5 and CXCL9, resulting in a reduced number of 
migrated cells. However, the latter results could not be associ-
ated with the observed differences between abortigenic or 
neurovirulent variants. Indeed, sequence analysis of gG of 
the abortigenic EHV1 strains and neurovirulent 03P37 EHV1 
strain did not show any difference in nucleotide or amino acid 
sequence. Based on the several differences in the immune 
evasion strategy of the abortigenic and neurovirulent EHV1 
phenotype [24, 25, 30–33], we hypothesized that both variants 
possibly not only differ in ORF30 [29, 65], but also in other 
(non-)structural viral proteins. Although gG is expressed with 
early viral gene kinetics, blocking the transcription of late 
viral proteins of the abortigenic variant resulted in increased 
recruitment of mononuclear cells to supernatants of infected 
ERECs, indicating that additional, late viral proteins may also 
be involved (data not shown). Intriguingly, Whittaker et al. 
[42] reported similarities in glycosylation, and lectin-binding 
capacities between EHV1 gp2 and HSV2 gG. First, we inocu-
lated ERECs with EHV1-∆gp2 and analysed the replication 
kinetics. Interestingly, we found a significant reduction in 
the number of viral plaques in ERECs when gp2 was deleted, 
compared to the parental strain. These results are in line with 
the in vitro study of Rudolph and Osterrieder [47]. This is not 
surprising given that gp2 is heavily O-glycosylated. Iversen 
and colleagues [66] demonstrated that O-linked sugars of 
HSV2 are essential for optimal viral entry. Virus pretreatment 
with specific enzymes to remove O-linked sugar moieties 
from the EHV1 surface would be an interesting first analysis 
to specify the role of O-linked sugars during EHV1 entry 
in ERECs. In addition, those specific sugar moieties on gp2 
could have considerable effects on the protein conformation 
as well as protein assembly, stability and function [67, 68]. It is 
important to note that all results concerning gp2 in this paper 
are based on the abortigenic RacL11 strain. However, based 
on our results, we hypothesized that gp2 of EHV1 might 
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have similar chemokine-binding activities as gG. Indeed, we 
found that deletion of the unique gp2 resulted in an increased 
chemotaxis of mainly T lymphocytes, and to a lesser extent 
monocytic CD172a+ cells, compared to the parental strain. 
These results are in line with the in vivo study of Wimer et al. 
[69]. They demonstrated in vivo that the occurrence of fever 
is delayed/accelerated depending on the presence/absence 
of gp2 in the viral strain. However, they could not correlate 
gp2 with increased infection of mononuclear cells and thus 
increased viraemia. Therefore, more research is required to 
elucidate the specific role of gp2 in the recruitment of mono-
nuclear cells to the site of infection for both EHV1 variants.
In conclusion, we have demonstrated that the in vitro 
culture of ERECs represents an efficient model to analyse 
virus-induced upregulation and bioactivity of chemokines. 
Replication of the EHV1 neurovirulent strain and to a lesser 
extent abortigenic EHV1 strain enhances the expression of 
specific chemokines in the URT. We showed that EHV1 repli-
cation in ERECs induces the production of biologically active 
chemokines, such as CXCL9 and CXCL10, which efficiently 
attract mononuclear cells. Moreover, we showed an enhanced 
recruitment of monocytic CD172a+ cells and T lymphocytes 
upon infection with neurovirulent 03P37 and 95P105 EHV1 
compared with the abortigenic 97P70 and 438/77 EHV1 
strain. We confirmed that gG of EHV1 plays a crucial role 
in the chemotaxis of mononuclear target cells to the primary 
site of replication. Alongside the early viral protein gG, we 
demonstrated that gp2 impedes the recruitment of mononu-
clear cells in the in vitro EREC model.
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